Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–218 of 218
Sabbagh, M. N. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.535 · Cited by 52
Amyloid imaging in dementias with atypical presentation
Wolk, D. A., Price, J. C., Madeira, C., Saxton, J. A., Snitz, B. E., Lopez, O. L., Mathis, C. A., Klunk, W. E., & DeKosky, S. T. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.07.003 · Cited by 49
Wong, D. F., Moghekar, A. R., Rigamonti, D., Brašić, J. R., Rousset, O., Willis, W., Buckley, C., Smith, A., Gok, B., Sherwin, P., et al. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0583-x · Cited by 45
Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials
Andrews, K. A., Modat, M., Macdonald, K. E., Yeatman, T., Cardoso, M. J., Leung, K. K., Barnes, J., Villemagne, V. L., Rowe, C. C., Fox, N. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058816 · Cited by 44
Self-citationApostolova, L. G., Haider, J. M., Goukasian, N., Rabinovici, G. D., Chételat, G., Ringman, J. M., Kremen, S., Grill, J. D., Restrepo, L., Mendez, M. F., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.12.001 · Cited by 39
Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview
Morris, J. C., & Selkoe, D. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.005 · Cited by 37
Sojkova, J., & M. Resnick, S. (2011) · Current Alzheimer Research · doi:10.2174/156720511795745375 · Cited by 36
Amyloid PET Ligands for Dementia
Villemagne, V. L., & Rowe, C. C. (2010) · PET Clinics · doi:10.1016/j.cpet.2009.12.008 · Cited by 32
Self-citationIntegrity, Mayhem, and the Question of Self-demand Amputation
Sullivan, N. (2005) · Continuum · doi:10.1080/10304310500176487 · Cited by 32
Amyloid imaging in prodromal Alzheimer's disease
Ossenkoppele, R., van Berckel, B. N. M., & Prins, N. D. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt88 · Cited by 27
Is Tau Imaging More Than Just Upside-Down 18F-FDG Imaging?
van Eimeren, T., Bischof, G. N., & Drzezga, A. E. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190082 · Cited by 25
Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis
Andrews, K. A., Frost, C. D., Modat, M., Cardoso, M. J., Rowe, C. C., Villemagne, V. L., Fox, N. C., Ourselin, S., Schott, J. M., Rowe, C. C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.013 · Cited by 24
Self-citationDistinct tau PET imaging patterns in typical and atypical Alzheimer’s disease
Sarazin, M., Lagarde, J., & Bottlaender, M. (2016) · Brain · doi:10.1093/brain/aww041 · Cited by 20
Effects of transthyretin on thyroxine and β‐amyloid removal from cerebrospinal fluid in mice
Chen, R., Chen, C. P., & Preston, J. E. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12598 · Cited by 19
Royall, D. R. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.008 · Cited by 17
Pro: Can biomarkers be gold standards in Alzheimer's disease?
Sperling, R. A., & Johnson, K. A. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt41 · Cited by 16
Tau imaging in progressive supranuclear palsy
Pérez‐Soriano, A., & Stoessl, A. J. (2016) · Movement Disorders · doi:10.1002/mds.26851 · Cited by 7
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021
Porsteinsson, A. P., Isaacson, R. S., Knox, S., Sabbagh, M. N., & Rubino, I. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.23 · Cited by 744
“…amyloid plaques; a positive amyloid PET scan will show increased cortical retention of the tracer in regions of Aβ deposition within the brain (74), thus confirming the presence of Aβ plaques in the brain (74, 75) and directly quantify brain amyloid pathology (76), thus making it a useful…”
InfluentialThe amyloid hypothesis in Alzheimer disease: new insights from new therapeutics
Karran, E., & De Strooper, B. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00391-w · Cited by 742
Tau PET imaging in neurodegenerative tauopathies—still a challenge
Leuzy, A., Chiotis, K., Lemoine, L., Gillberg, P.-G., Almkvist, O., Rodriguez-Vieitez, E., & Nordberg, A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0342-8 · Cited by 628
Metadata
- Authors
- Villemagne, V. L., Doré, V., Burnham, S. C., Masters, C. L., & Rowe, C. C.
- Venue
- Nature Reviews Neurology
- Published
- 2018-02-16
- Volume
- 14
- Issue
- 4
- Pages
- 225-236
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2786084903
- Cited by
- 441
- References
- 218
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.